Author

F. Béthoux

Observed names: Bethoux, F., FA Bethoux

Institution: Cleveland Clinic

Observed institutions: Cleveland Clinic, University of Rochester Medicine, Acorda Therapeutics (United States), Evergreen Health Medical Center, University of Rochester

OpenAlex ID: A5087731307

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

2015 · Andrew D Goodman, Francois Bethoux, et al. · Multiple Sclerosis Journal · 53

Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study

2018 · U. Dalgas, M. Langeskov-Christensen, et al. · Journal of the Neurological Sciences · 37

A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations

2000 · D.M. Miller, B. Weinstock-Guttman, et al. · Multiple Sclerosis Journal · 15

Évaluation et sclérose en plaques

2005 · F. Béthoux · Annales de Réadaptation et de Médecine Physique · 11

Works count: 5

Citation count: 116

H-index: 4

I10-index: 4